Teladoc Health, Inc. (TDOC): who owns it and who trades it
As of Nov 16, 2026, TDOC insiders reported 38 open-market sales worth $2.7M and no purchases in the last 12 months, with 29% of the sale value made under pre-set 10b5-1 plans. The largest seller was Charles Divita III (CEO), with $1M. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Teladoc Health
From the latest filingsOverall: more selling than buying. Insiders and famous investors mostly sold. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns TDOC
344 funds and institutions reported TDOC shares worth $1.3B at the end of Q2 2026, about 86% of the company. The largest holder is BlackRock, Inc. with 9.0%.
Funds and institutions (13F) 86%Everyone else 14%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 16.22M | 8.99% | $138M | +11% |
| Vanguard Portfolio Management LLC | 12.69M | 7.03% | $108M | +3% |
| Point72 Asset Management, L.P. | 8.24M | 4.56% | $69.9M | +7% |
| Renaissance Technologies LLC | 8.07M | 4.47% | $68.5M | -0% |
| Voss Capital, LP | 8.05M | 4.46% | $68.2M | +92% |
| Vanguard Capital Management LLC | 7.96M | 4.41% | $67.5M | +1% |
| Dimensional Fund Advisors LP | 7.37M | 4.08% | $62.5M | +17% |
| State Street Corp | 4.96M | 2.75% | $42.1M | +14% |
| American Century Companies Inc | 4.89M | 2.71% | $41.5M | +42% |
| Allianz Asset Management GmbH | 4.67M | 2.59% | $39.6M | -3% |
| Geode Capital Management, LLC | 4.65M | 2.58% | $39.5M | +11% |
| Goldman Sachs Group Inc | 3.82M | 2.12% | $32.4M | +41% |
| Monaco Asset Management SAM | 3.17M | 1.75% | $26.9M | -21% |
| Jupiter Asset Management Ltd | 3.11M | 1.72% | $26.4M | No change |
| Charles Schwab Investment Management Inc | 3.06M | 1.70% | $26M | +1% |
| Sixth Street Partners Management Company, L.P. | 3.06M | 1.70% | $26M | – |
| Quantinno Capital Management LP | 2.82M | 1.56% | $23.9M | +8% |
| Federated Hermes, Inc. | 2.13M | 1.18% | $18M | +25% |
| UBS Group AG | 2.05M | 1.14% | $17.4M | +19% |
| Arrowstreet Capital, Limited Partnership | 2.04M | 1.13% | $17.3M | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, TDOC insiders reported $0 of open-market purchases and $2.7M of sales. 29% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Carlos Nueno | President | Sale plan | 29,432 | $9.20 | $271K | Form 4 |
| Oct 2, 2026 | Joseph Ronald Catapano | Chief Accounting Officer | Sale | 655 | $5.65 | $3.7K | Form 4 |
| Sep 11, 2026 | Charles Divita III | CEO | Sale | 17,805 | $6.10 | $109K | Form 4 |
| Sep 3, 2026 | Fernando M. Rodrigues | President | Sale plan | 9,812 | $6.51 | $63.9K | Form 4 |
| Sep 2, 2026 | Carlos Nueno | President | Sale | 6,200 | $6.30 | $39.1K | Form 4 |
| Sep 2, 2026 | Adam C Vandervoort | CHIEF LEGAL OFFICER | Sale | 7,573 | $6.30 | $47.7K | Form 4 |
| Sep 2, 2026 | Kelly Bliss | President | Sale | 7,357 | $6.30 | $46.3K | Form 4 |
| Sep 2, 2026 | Joseph Ronald Catapano | Chief Accounting Officer | Sale | 274 | $6.30 | $1.7K | Form 4 |
| Sep 2, 2026 | Charles Divita III | CEO | Sale | 18,327 | $6.30 | $115K | Form 4 |
| Sep 2, 2026 | Fernando M. Rodrigues | President | Sale plan | 5,439 | $6.30 | $34.3K | Form 4 |
| Jul 6, 2026 | Kelly Bliss | President | Sale plan | 2,500 | $9.50 | $23.8K | Form 4 |
| Jul 2, 2026 | Joseph Ronald Catapano | Chief Accounting Officer | Sale | 653 | $9.10 | $5.9K | Form 4 |
| Jul 1, 2026 | Kelly Bliss | President | Sale plan | 2,500 | $9.00 | $22.5K | Form 4 |
| Jun 29, 2026 | Kelly Bliss | President | Sale plan | 2,500 | $8.50 | $21.2K | Form 4 |
| Jun 11, 2026 | Charles Divita III | CEO | Sale | 18,074 | $6.94 | $125K | Form 4 |
| Jun 3, 2026 | Fernando M. Rodrigues | President | Sale plan | 9,572 | $7.40 | $70.8K | Form 4 |
| Jun 2, 2026 | Fernando M. Rodrigues | President | Sale | 5,677 | $7.63 | $43.3K | Form 4 |
| Jun 2, 2026 | Adam C Vandervoort | CHIEF LEGAL OFFICER | Sale | 7,906 | $7.63 | $60.3K | Form 4 |
| Jun 2, 2026 | Carlos Nueno | President | Sale | 6,196 | $7.63 | $47.3K | Form 4 |
| Jun 2, 2026 | Charles Divita III | CEO | Sale | 19,132 | $7.63 | $146K | Form 4 |
| Jun 2, 2026 | Joseph Ronald Catapano | Chief Accounting Officer | Sale | 284 | $7.63 | $2.2K | Form 4 |
| Jun 2, 2026 | Kelly Bliss | President | Sale | 7,679 | $7.63 | $58.6K | Form 4 |
| Apr 2, 2026 | Joseph Ronald Catapano | Chief Accounting Officer | Sale | 675 | $5.11 | $3.4K | Form 4 |
| Mar 11, 2026 | Charles Divita III | CEO | Sale | 27,731 | $5.49 | $152K | Form 4 |
| Mar 3, 2026 | Fernando M. Rodrigues | President | Sale plan | 25,086 | $4.98 | $125K | Form 4 |
| Mar 2, 2026 | Adam C Vandervoort | CHIEF LEGAL OFFICER | Sale | 27,083 | $5.12 | $139K | Form 4 |
| Mar 2, 2026 | Carlos Nueno | President | Sale | 20,165 | $5.12 | $103K | Form 4 |
| Mar 2, 2026 | Fernando M. Rodrigues | President | Sale plan | 16,314 | $5.12 | $83.5K | Form 4 |
| Mar 2, 2026 | Charles Divita III | CEO | Sale | 50,145 | $5.12 | $257K | Form 4 |
| Mar 2, 2026 | Joseph Ronald Catapano | Chief Accounting Officer | Sale | 1,333 | $5.12 | $6.8K | Form 4 |
| Mar 2, 2026 | Kelly Bliss | President | Sale | 26,647 | $5.12 | $136K | Form 4 |
| Jan 5, 2026 | Joseph Ronald Catapano | Chief Accounting Officer | Sale | 758 | $7.15 | $5.4K | Form 4 |
| Dec 11, 2025 | Charles Divita III | CEO | Sale | 17,138 | $7.63 | $131K | Form 4 |
| Dec 3, 2025 | Fernando M. Rodrigues | President | Sale plan | 4,209 | $7.48 | $31.5K | Form 4 |
| Dec 2, 2025 | Fernando M. Rodrigues | President | Sale plan | 2,324 | $7.49 | $17.4K | Form 4 |
| Dec 2, 2025 | Adam C Vandervoort | CHIEF LEGAL OFFICER | Sale | 5,720 | $7.49 | $42.8K | Form 4 |
| Dec 2, 2025 | Carlos Nueno | President | Sale | 3,897 | $7.49 | $29.2K | Form 4 |
| Dec 2, 2025 | Kelly Bliss | President | Sale | 4,582 | $7.49 | $34.3K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Charles Divita III | CHIEF EXECUTIVE OFFICER, Director | – | $1M | Sep 11, 2026 |
| Carlos Nueno | President, International | – | $490K | Nov 6, 2026 |
| Fernando M. Rodrigues | President of BetterHelp | – | $470K | Sep 3, 2026 |
| Kelly Bliss | President, U.S. Group Health | – | $343K | Sep 2, 2026 |
| Adam C Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | – | $290K | Sep 2, 2026 |
| Joseph Ronald Catapano | Chief Accounting Officer | – | $29.2K | Oct 2, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
TDOC short interest
High short interest. 17.7% of TDOC shares are sold short: about 1 share in 6. Over the last 12 reports the number of shares short went up 21%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 32.19M TDOC shares were sold short, 17.7% of the shares outstanding, up 0.4% from the report before. At the average daily volume of 5.69M shares, buying them all back would take about 5.7 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 32.19M | 17.66% | +0% | 5.69M | 5.7 |
| Oct 15, 2026 | 32.07M | 17.65% | +7% | 3.91M | 8.2 |
| Sep 30, 2026 | 30.10M | 16.57% | +9% | 3.37M | 8.9 |
| Sep 15, 2026 | 27.63M | 15.21% | +9% | 3.25M | 8.5 |
| Aug 31, 2026 | 25.34M | 13.95% | +7% | 3.53M | 7.2 |
| Aug 14, 2026 | 23.69M | 13.04% | -10% | 4.74M | 5.0 |
| Jul 31, 2026 | 26.30M | 14.48% | -6% | 6.65M | 4.0 |
| Jul 15, 2026 | 28.06M | 15.54% | +2% | 4.26M | 6.6 |
| Jun 30, 2026 | 27.42M | 15.19% | -7% | 4.79M | 5.7 |
| Jun 15, 2026 | 29.44M | 16.31% | +6% | 3.98M | 7.4 |
| May 29, 2026 | 27.71M | 15.35% | +5% | 4.40M | 6.3 |
| May 15, 2026 | 26.51M | 14.69% | -10% | 5.78M | 4.6 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Teladoc Health company events
Teladoc Health filed 14 reports on Form 8-K in the last 12 months, 9 of them about an important change (leadership). The latest was on Oct 28, 2026.
- Oct 28, 2026ResultsReleased financial results. Filing
- Sep 25, 2026LeadershipMr. Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, Inc., informed the Company of his decision to resign, effective November 1, 2026. Filing
- Aug 31, 2026LeadershipTeladoc Health, Inc. hired Michael Grasher as its Chief Financial Officer. Filing
- Aug 13, 2026LeadershipMr. David B. Snow, Jr. notified Teladoc Health, Inc. of his intention to retire from the Board effective as of September 30, 2026. Filing
- Aug 3, 2026LeadershipThe Board of Directors of Teladoc Health, Inc. increased the number of directors on the Board to ten and appointed Mark V. Anquillare as a director of the Company. Filing
- Jul 29, 2026ResultsReleased financial results. Filing
- May 21, 2026VoteReported shareholder vote results. Filing
- Apr 29, 2026ResultsReleased financial results. Filing
- Mar 30, 2026LeadershipThe Board of Directors of Teladoc Health, Inc. increased the number of directors on the Board to nine and appointed Susan R. Salka as a director of the Company. Filing
- Feb 25, 2026ResultsReleased financial results. Filing
- Feb 18, 2026LeadershipThe Board of Directors of Teladoc Health, Inc. increased the number of directors on the Board to ten and appointed Michael S. Smith as a director of the Company. Filing
- Feb 12, 2026LeadershipMr. Thomas G. McKinley notified Teladoc Health, Inc. of his intention to retire from the Board effective as of February 20, 2026. Filing
- Dec 16, 2025LeadershipMr. J. Eric Evans notified Teladoc Health, Inc. of his intention not to stand for reelection at the Company’s 2026 Annual Meeting of Stockholders and to retire from the Board effective as of the conclusion of the Annual Meeting. Filing
- Dec 12, 2025LeadershipTeladoc Health, Inc. amended its 2023 Employment Inducement Incentive Award Plan (as amended, the “2023 Inducement Plan”) solely to increase the number of shares of common stock, par value $0.001 per share, reserved for issuance under the 2023 Inducement Plan by 1,780,000 shares, to a new total of… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Teladoc Health financials
Famous investors that hold TDOC
5 of the 50 well-known investors we track reported holding TDOC in their latest 13F filing. The largest position is Jim Simons's, worth $46.4M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 8.00M | $46.4M | 0.1% | -1% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 7.95M | $46.1M | 0.1% | -3% |
| Israel Englander · Millennium Management | Q3 2026 | 317,351 | $1.8M | 0.0% | +118% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 78,016 | $452K | 0.0% | -90% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 11,339 | $65.8K | 0.0% | -4% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named TDOC in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 8, 2026 | Dimensional Fund Advisors LP | 13G | 5.0% |
| Oct 8, 2026 | Dimensional Fund Advisors LP | 13G | 5.0% |
Questions about Teladoc Health, Inc. (TDOC) stock
Who owns the most TDOC stock?
The largest reported owner of Teladoc Health, Inc. (TDOC) is BlackRock, Inc., with 9.0% of the company. In total, 344 funds and institutions reported holding TDOC at the end of Q2 2026, together about 86% of the shares. See the largest owners.
Are TDOC insiders buying or selling?
In the last 12 months, TDOC insiders reported no open-market purchases and 38 sales worth $2.7M. The latest trade was on Nov 6, 2026. See every trade.
What is the short interest in TDOC?
As of Oct 30, 2026, 32.19M TDOC shares were sold short, 17.7% of the shares outstanding, up 0.4% from the report before. At the average daily volume of 5.69M shares, buying them all back would take about 5.7 trading days (days to cover). See the history.
Which famous investors hold TDOC?
5 of the 50 well-known investors we track reported TDOC in their latest 13F filing, including Jim Simons, Steve Cohen, Israel Englander. The largest position is worth $46.4M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.